News Articles Tagged: Leukemia Resistance

The Role of G-749 in Overcoming FLT3-Mediated Drug Resistance in Leukemia

Investigate how G-749, a powerful FLT3 inhibitor, offers solutions to drug resistance in leukemia treatment, enabling new therapeutic strategies.

Selinexor and CLL: Targeting Resistance with Novel Combinations

Examine the research on Selinexor's role in targeting drug resistance in Chronic Lymphocytic Leukemia (CLL), highlighting how companies like NINGBO INNO PHARMCHEM CO.,LTD. support these advancements.

Synergistic Selinexor Combinations: A New Hope for Leukemia Patients

Explore the research showing how synergistic combinations of Selinexor with other drugs are improving outcomes for patients with Chronic Lymphocytic Leukemia (CLL), supported by companies like NINGBO INNO PHARMCHEM CO.,LTD.